epitopebas
vaccin
design
induc
antibodi
respons
specif
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
develop
mean
increas
vaccin
potenc
studi
identifi
four
b
cell
epitop
spike
membran
protein
bioinformat
analysi
construct
multiepitop
dna
vaccin
intramuscular
immun
mice
vaccin
suffici
induc
specif
prime
well
longterm
memori
humor
immun
respons
least
two
candid
epitop
dna
primeprotein
boost
strategi
greatli
enhanc
antibodi
gener
immun
sera
react
lysat
sarscovinfect
vero
cell
also
neutral
cytopath
effect
sar
dilut
novel
immunogen
protein
peptid
reveal
studi
provid
new
target
sar
vaccin
design
work
indic
multiepitop
dna
vaccin
effect
mean
elicit
polyval
humor
immun
respons
sarscov
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
etiolog
agent
caus
sar
sever
highli
contagi
infecti
diseas
spread
worldwid
year
sever
morbid
mortal
associ
sar
make
imper
effect
vaccin
prophylaxi
therapi
diseas
develop
evalu
although
lot
effort
made
understand
role
variou
immun
effector
protect
immun
identifi
protect
antigen
recogn
effector
cell
conclus
inform
avail
immun
correl
protect
sar
howev
convalesc
sera
report
effici
neutral
sarscov
infect
spikemedi
infect
could
inhibit
sera
sar
patient
sar
patient
deriv
antibodi
protein
effici
neutral
sarscov
infect
indic
neutral
antibodi
one
import
protect
immun
effector
sarscov
encod
four
major
structur
protein
known
nucleocapsid
n
protein
envelop
e
protein
membran
protein
spike
protein
protein
play
crucial
role
assembl
bud
virion
protein
critic
viral
bind
cellular
receptor
angiotensinconvert
enzym
receptor
bind
domain
rbd
henc
identif
neutral
epitop
within
sequenc
may
enabl
design
epitopebas
sar
vaccin
coupl
immunodomin
epitop
protein
sarscov
identifi
onlin
epitop
predic
softwar
epitop
map
technolog
use
potenti
vaccin
target
therapeut
reagent
multipl
b
cell
epitop
dna
vaccin
strategi
adopt
present
studi
sinc
epitopebas
approach
bring
vaccin
increas
safeti
possibl
ration
epitop
engin
accur
immun
focus
would
contribut
promot
potenc
breadth
specif
immun
respons
multiepitopebas
vaccin
design
induc
antibodi
respons
ctl
respons
specif
sarscov
virus
success
develop
mean
address
vaccin
potenc
viral
heterogen
screen
sarscov
spike
protein
protein
engin
dna
vaccin
separ
one
anoth
alaninealaninetyrosin
aay
spacer
evalu
hydrophil
surfac
probabl
hydrophob
antigen
valu
flexibl
secondari
structur
multiepitop
chimera
protein
perform
dnastar
softwar
synthet
nucleotid
sequenc
incorpor
vector
codon
optim
employ
construct
plasmid
present
studi
identifi
four
b
cell
epitop
protein
sarscov
dna
plasmid
vaccin
design
express
four
b
cell
epitop
singl
ag
test
immunogen
balbc
mice
intramuscular
inject
dna
vaccin
induc
antibodi
respons
sarscov
reactiv
serum
antibodi
four
epitop
evalu
dna
primeprotein
boost
strategi
util
improv
vaccin
effici
protect
activ
immun
sera
evalu
vitro
neutral
assay
sinc
two
identifi
human
coronavirus
trigger
mild
upper
respiratori
infect
lowhomolog
motif
rel
sarscov
design
first
screen
compar
sequenc
differ
chines
sarscov
isol
variou
coronavirus
sarscov
protein
sequenc
ncbi
genbank
databas
genbank
repres
canadian
isol
analyz
identifi
potenti
b
cell
epitop
accord
algorithm
concern
hydrophil
surfac
probabl
hydrophob
antigen
valu
flexibl
secondari
structur
use
dnastar
softwar
four
segment
design
select
construct
multiepitop
dna
vaccin
four
select
epitop
protein
engin
dna
vaccin
separ
one
anoth
aay
spacer
enhanc
appropri
epitop
process
fig
multiepitop
gene
construct
use
overlap
oligonucleotid
pcrbase
synthesi
sequenc
agatctgcc
acc
gagaagtccggcaactttaagcacttacgcgagtttgtgtttaagaacaaggacggctttctgtacgccgcctacaactacaagtacaggtacctgagacacggcaagctgaggccctttgagagagacatctccaacgtgcccgccgcctactccgacttcactgactccgttcgcgaccccaagacctccgccgcctacatggccgacaacggcaccatcaccgtggaggagctgaagcagctgctggagcagtggaac
gaattc
construct
includ
kozak
sequenc
bold
nterminu
gene
optim
mammalian
codon
usag
accord
previou
studi
synthet
nucleotid
sequenc
incorpor
express
vector
invitrogen
usa
invitrogen
usa
eukaryot
plasmid
vector
well
novagen
germani
prokaryot
vector
final
plasmid
identifi
pvaxepi
purifi
use
qiagen
megaprep
column
valencia
ca
accord
manufactur
instruct
adjust
mgml
pb
buffer
ph
plasmid
transform
escherichia
coli
strain
express
chimer
protein
tag
purifi
ni
affin
chromatographi
column
accord
manufactur
instruct
novagen
germani
elut
pb
futur
analysi
cell
transfect
use
lipofectamin
reagent
cell
lysat
supernat
collect
h
posttransfect
separ
sdspage
sampl
transfer
onto
nitrocellulos
membran
electroblot
membran
incub
monoclon
mous
antimyc
antibodi
santa
cruz
usa
c
overnight
hrpconjug
goat
antimous
igg
santa
cruz
usa
c
h
wash
membran
develop
enhanc
chemiluminesc
kit
piec
corp
usa
balbc
mice
intramuscularli
inject
g
mock
plasmid
h
later
quadricep
surgic
remov
made
frozen
section
section
dri
c
min
fix
aceton
treat
h
methanol
quench
endogen
peroxidas
block
normal
serum
incub
monoclon
mous
antimyc
tag
antibodi
biotinyl
secondari
antibodi
abc
reagent
use
follow
protocol
abc
kit
rtu
vectastain
univers
vector
lab
dab
stain
balbc
mice
obtain
shanghai
laboratori
anim
center
chines
academi
scienc
anim
hous
pathogenfre
mous
coloni
anim
experi
perform
accord
guidelin
care
use
medic
laboratori
anim
ministri
health
pr
china
guidelin
laboratori
anim
ethic
commiss
fudan
univers
mice
inject
g
pvaxepi
mock
plasmid
l
pb
tibiali
anterior
muscl
two
leg
week
g
chimer
protein
l
pb
administ
subcutan
sc
week
boost
immun
optim
primeboost
strategi
g
pvaxepi
dna
im
immun
follow
three
g
chimer
protein
boost
week
blood
sampl
collect
retroorbit
bleed
elisa
plate
coat
gml
individu
synthes
epitop
peptid
mix
synthes
peptid
purifi
prokaryot
express
sarscov
protein
fragment
shukang
biotechnolog
shanghai
c
overnight
block
goat
serum
pbst
pb
tween
h
wash
serum
sampl
ad
duplic
incub
c
h
anoth
three
time
wash
hrpcoupl
goat
antimous
igg
sigmaaldrich
usa
ad
color
develop
opd
reaction
stop
h
absorpt
nm
measur
micropl
reader
biolab
usa
antisera
week
deriv
mice
receiv
dna
prime
week
protein
boost
week
use
western
blot
analysi
neutral
assay
inactiv
sarscov
strain
iv
china
lysat
provid
biosafeti
level
laboratori
wuhan
institut
biolog
product
china
mix
equal
volum
load
buffer
mm
trishcl
ph
mm
dtt
sd
bromophenol
blue
glycerol
separ
sdspolyacrylamid
gel
electrophoresi
page
protein
band
transfer
onto
nitrocellulos
membran
block
skim
milk
pb
h
membran
incub
dilut
serum
overnight
c
hrpconjug
goat
antimous
igg
h
c
color
develop
enhanc
chemiluminesc
kit
piec
corp
usa
viru
neutral
assay
perform
biosafeti
level
laboratori
vero
cell
maintain
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
uml
penicillin
g
per
ml
gml
streptomycin
viral
infect
perform
ad
l
medium
contain
tcid
sarscov
strain
iv
china
l
serial
twofold
dilut
serum
premix
l
tcid
sarscov
h
plate
contain
cell
per
well
cytopath
effect
cpe
observ
h
afterward
microscopi
confirm
crystal
violet
stain
cpe
cell
blindli
evalu
two
pathologist
scale
repres
cell
viabil
repres
cell
death
apoptosi
repres
cell
death
apoptosi
repres
cell
death
apoptosi
repres
cell
death
apoptosi
data
present
mean
standard
deviat
oneway
anova
test
use
compar
differ
antibodi
titer
group
mice
differ
two
group
mice
compar
use
wilcoxonmatch
pair
test
probabl
less
taken
signific
statist
calcul
perform
use
graphpad
prism
version
statist
program
protein
screen
potenti
b
cell
epitop
use
epitop
predict
softwar
onlin
four
candid
b
cell
epitop
design
eksgnfkhlrefvfknkdgfli
nykyrylrhgklrpferdisnvp
sdftdsvrdpkt
madngtitveelkqlleqwn
select
construct
multiepitop
dna
vaccin
fig
vitro
express
multiepitop
gene
first
demonstr
use
prokaryot
express
system
correspond
multiepitop
protein
fuse
trxa
fragment
tag
express
cell
purifi
ni
affin
chromatographi
shown
fig
multiepitop
construct
well
express
vitro
molecular
weight
kda
immunogen
prokaryot
express
protein
prove
sc
inject
g
chimera
protein
mice
emulsifi
complet
freund
adjuv
cfa
result
induct
peptidespecif
serum
igg
week
postimmun
fig
multiepitop
chimera
gene
also
clone
eukaryot
express
vector
vitro
transfect
effici
evalu
cell
use
lipofectamin
reagent
multiepitop
chimera
protein
express
cell
lysat
confirm
western
blot
fig
assess
express
distribut
chimera
gene
vivo
tibiali
anterior
muscl
mice
stain
antimyc
ab
h
g
dna
administr
shown
fig
eukaryot
encod
multiepitop
gene
well
express
vivo
determin
immunogen
multiepitop
sarscov
dna
vaccin
balbc
mice
receiv
inject
g
pvaxepi
mock
dna
week
interv
shown
fig
signific
increas
igg
level
observ
multiepitop
dna
immun
mice
specif
serum
igg
titer
increas
time
reach
peak
week
amount
declin
singl
g
prokaryot
chimera
protein
boost
week
quickli
restor
humor
respons
higher
extent
igg
titer
indic
multiepitop
dna
vaccin
elicit
prime
memori
immun
respons
last
least
month
howev
prime
mock
dna
follow
protein
boost
could
achiev
rel
weak
immun
respons
reactiv
antisera
individu
epitop
peptid
show
peptid
highli
immunogen
serum
antibodi
induct
epitop
rel
weak
immunogen
fig
immun
sera
could
also
recogn
prokaryot
express
protein
data
shown
variou
dna
primeprotein
boost
strategi
investig
promot
vaccin
effici
mice
prime
one
dnaprotein
inject
week
boost
three
prokaryot
chimera
protein
sc
immun
week
last
protein
boost
extrem
higher
level
serum
igg
titer
amount
near
seen
dna
primingprotein
boost
immun
mice
fig
p
indic
multiepitop
sarscov
dna
vaccin
elicit
potent
sarsspecif
prime
antibodi
respons
could
synergist
amplifi
follow
protein
antigen
immun
week
immun
sera
mice
treat
dna
primeprotein
boost
fig
first
investig
bind
capac
sarscov
protein
western
blot
assay
dilut
serum
shown
bind
protein
lysat
viral
infect
vero
cell
mw
kda
equival
mw
report
protein
fig
prokaryot
express
protein
data
shown
indic
antisera
could
recogn
nativ
protein
express
sarscov
determin
virusneutr
activ
immun
sera
ccid
dose
sarscov
incub
serial
dilut
serum
use
infect
cell
monolay
although
serum
could
total
block
viral
infect
found
dilut
sera
reduc
inject
g
pvaxepi
plasmid
tibiali
anterior
muscl
week
g
prokaryot
express
chimer
multiepitop
protein
sc
inject
week
n
week
n
boost
immun
specif
igg
level
dilut
sera
reactiv
mix
epitop
measur
elisa
assay
arrow
indic
time
point
dna
inject
p
compar
group
p
p
compar
mock
dna
prime
group
b
specif
reactiv
week
serum
four
individu
predict
epitop
peptid
investig
elisa
assay
p
sarscovspecif
humor
immun
respons
greatli
augment
use
modifi
dna
primeprotein
boost
strategi
four
group
mice
prime
g
pvaxepi
dna
im
immun
g
chimer
protein
sc
inject
follow
three
chimer
protein
g
boost
week
specif
serum
igg
titer
determin
elisa
assay
p
compar
protein
prime
adjuv
cpe
percentag
cell
tabl
indic
serum
antibodi
target
predict
spike
epitop
could
partial
neutral
infect
viru
attenu
virul
sarscov
strain
use
although
sar
eventu
contain
stringent
applic
infect
control
measur
high
infect
rate
inexact
anim
reservoir
sarscov
rais
continu
concern
viral
recurr
urgent
need
effect
safe
vaccin
develop
prevent
reemerg
epidem
futur
multiepitopebas
vaccin
design
increas
vaccin
potenc
viral
heterogen
ideal
candi
date
vaccin
control
sar
epidem
use
bioinformat
tool
phagedisplay
peptid
librari
techniqu
panel
antigen
epitop
could
identifi
easili
deliv
context
dna
viral
vector
immun
protein
sarscov
compris
major
antigen
determin
induc
neutral
ab
make
major
target
vaccin
design
immun
therapi
immun
respons
target
well
protein
abl
neutral
sarscov
infect
take
account
three
b
epitop
protein
one
b
epitop
protein
sarscov
select
construct
multiepitop
chimer
dna
vaccin
intramuscular
inject
dna
vaccin
provok
potent
medium
control
serum
pvaxtreat
mice
nonspecif
igg
control
sera
dnaproteintr
mice
prime
rel
longterm
month
memori
antibodi
respons
sar
protein
would
potenti
protect
effect
prevent
sarscov
epidem
howev
predict
epitop
immunolog
recogn
immun
sera
fig
may
due
phenomenon
b
cell
immunodomin
tend
focu
immun
respons
rel
domin
epitop
antigen
first
antigen
avail
regul
hierarchi
peptid
epitop
fold
serial
connect
polyepitop
protein
may
caus
steric
hindranc
certain
epitop
expos
other
bcr
second
competit
cytokin
may
also
influenc
level
b
cell
prime
expans
interest
although
epitop
immunogen
could
recogn
sera
fig
western
blot
fail
detect
predict
band
correspond
protein
viral
lysat
one
possibl
reason
first
amino
acid
protein
might
serv
signal
peptid
may
remov
viral
protein
result
demonstr
specif
immun
sera
elicit
dna
primeprotein
boost
immun
protect
neutral
cytopath
effect
sar
consist
fragment
protein
report
critic
bind
indic
epitoperich
import
immunodomin
domain
sarscov
nearbi
epitop
also
predict
neutral
b
cell
epitop
therefor
epitop
identifi
studi
repres
anoth
immunogen
potenti
protect
b
cell
epitop
protein
dna
primeprotein
boost
immun
strategi
employ
studi
enhanc
effect
multiepitop
dna
vaccin
primeboost
vaccin
strategi
synergist
amplifi
specif
immun
meanwhil
select
b
cell
greater
avid
increas
number
memori
cell
specif
share
antigen
prime
boost
vaccin
seen
fig
igg
titer
induc
dna
primeprotein
boost
strategi
mount
week
post
immun
much
higher
induc
proteinprotein
vaccin
contribut
mechan
might
effici
stimul
antigenspecif
memori
b
cell
dna
prime
immun
mainten
memori
b
cell
popul
might
independ
antigen
persist
memori
b
cell
must
stimul
antigen
differenti
shortliv
antibodysecret
plasma
cell
therefor
vaccin
induc
longterm
protect
antibodi
titer
repeatedli
provid
continu
mainten
antigen
minim
quantiti
prolong
time
period
desper
need
suffici
number
memori
b
cell
matur
plasma
cell
dna
transgen
express
persist
much
longer
cognat
protein
due
intrins
express
properti
exogen
protein
degrad
vivo
quickli
time
plasmid
dna
persist
stabli
express
antigen
least
month
rna
protein
level
longterm
stabil
plasmid
dna
muscl
even
last
month
studi
express
dnaencod
gene
could
detect
least
week
muscl
data
shown
explain
best
memori
antibodi
respons
induc
dna
prime
week
cell
help
cytokin
also
requir
stimul
memori
b
cell
potent
adjuv
properti
cpg
nucleotid
sequenc
dna
vector
effici
stimul
apc
upregul
express
cytokin
costimulatori
molecul
need
expans
b
memori
b
cell
therefor
dna
prime
strategi
effect
protein
prime
stimul
function
longterm
memori
b
cell
respons
consist
lot
recent
report
demonstr
efficaci
dna
primeprotein
boost
protocol
augment
antibodi
level
taken
togeth
multiepitop
dna
vaccin
capabl
stimul
longterm
humor
immun
respons
control
sarscov
infect
design
show
two
epitop
critic
import
gener
immun
potenti
protect
effect
heterolog
dna
primeprotein
boost
immun
demonstr
effect
elev
antibodi
respons
